Moichor
Moichor provides AI-enhanced laboratory diagnostics to improve veterinary patient outcomes through automated microscopy and image analysis. The company combines automated microscopy hardware with computer vision and artificial intelligence models to generate diagnostic reference data across animal species. Moichor operates as an animal reference laboratory serving veterinarians and veterinary clinics, applying laboratory workflows and AI models to species that previously lacked reference ranges. The offering sits at the intersection of diagnostic labs and AI-enabled clinical tools, positioning it as a B2B provider in the veterinary diagnostics market.
Moichor
Moichor provides AI-enhanced laboratory diagnostics to improve veterinary patient outcomes through automated microscopy and image analysis. The company combines automated microscopy hardware with computer vision and artificial intelligence models to generate diagnostic reference data across animal species. Moichor operates as an animal reference laboratory serving veterinarians and veterinary clinics, applying laboratory workflows and AI models to species that previously lacked reference ranges. The offering sits at the intersection of diagnostic labs and AI-enabled clinical tools, positioning it as a B2B provider in the veterinary diagnostics market.
TL;DR
Company: Moichor — AI-enhanced veterinary diagnostics (Pathview) focusing on hematology and cytology
Headquarters: San Francisco, CA
Founded: 2017
Employees: 23
Notable investors: Neotribe Ventures, Y Combinator
Latest funding: Seed (Apr 15, 2021) — $4,045,000
Company Overview
Problem Domain
Veterinary diagnostics; automated hematology and cytology for diverse animal species
Founded
2017
Industry
Biotechnology
Funding Track Record
4045000 USD
Y Combinator listed as an investor in the round
Investor Signal
“Y Combinator; Neotribe Ventures”